Literature DB >> 22565811

Patient-reported speech in noise difficulties and hyperacusis symptoms and correlation with test results.

Chrysa Spyridakou1, Linda M Luxon, Doris E Bamiou.   

Abstract

OBJECTIVES/HYPOTHESIS: To compare self-reported symptoms of difficulty hearing speech in noise and hyperacusis in adults with auditory processing disorders (APDs) and normal controls; and to compare self-reported symptoms to objective test results (speech in babble test, transient evoked otoacoustic emission [TEOAE] suppression test using contralateral noise). STUDY
DESIGN: A prospective case-control pilot study.
METHODS: Twenty-two participants were recruited in the study: 10 patients with reported hearing difficulty, normal audiometry, and a clinical diagnosis of APD; and 12 normal age-matched controls with no reported hearing difficulty. All participants completed the validated Amsterdam Inventory for Auditory Disability questionnaire, a hyperacusis questionnaire, a speech in babble test, and a TEOAE suppression test using contralateral noise.
RESULTS: Patients had significantly worse scores than controls in all domains of the Amsterdam Inventory questionnaire (with the exception of sound detection) and the hyperacusis questionnaire (P < .005). Patients also had worse TEOAE suppression test results in both ears than controls; however, this result was not significant after Bonferroni correction. Strong correlations were observed between self-reported symptoms of difficulty hearing speech in noise and speech in babble test results in the right ear (ρ = 0.624, P = .002), and between self-reported symptoms of hyperacusis and TEOAE suppression test results in the right ear (ρ = -0.597 P = .003).
CONCLUSIONS: There was no significant correlation between the two tests. A strong correlation was observed between right ear speech in babble and patient-reported intelligibility of speech in noise, and right ear TEOAE suppression by contralateral noise and hyperacusis questionnaire.
Copyright © 2012 The American Laryngological, Rhinological, and Otological Society, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22565811     DOI: 10.1002/lary.23337

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  5 in total

1.  Speech Comprehension Difficulties in Chronic Tinnitus and Its Relation to Hyperacusis.

Authors:  Veronika Vielsmeier; Peter M Kreuzer; Frank Haubner; Thomas Steffens; Philipp R O Semmler; Tobias Kleinjung; Winfried Schlee; Berthold Langguth; Martin Schecklmann
Journal:  Front Aging Neurosci       Date:  2016-12-15       Impact factor: 5.750

2.  Long-term use benefits of personal frequency-modulated systems for speech in noise perception in patients with stroke with auditory processing deficits: a non-randomised controlled trial study.

Authors:  Nehzat Koohi; Deborah Vickers; Jason Warren; David Werring; Doris-Eva Bamiou
Journal:  BMJ Open       Date:  2017-04-07       Impact factor: 2.692

3.  Clinical validation of a public health policy-making platform for hearing loss (EVOTION): protocol for a big data study.

Authors:  Giorgos Dritsakis; Dimitris Kikidis; Nina Koloutsou; Louisa Murdin; Athanasios Bibas; Katherine Ploumidou; Ariane Laplante-Lévesque; Niels Henrik Pontoppidan; Doris-Eva Bamiou
Journal:  BMJ Open       Date:  2018-02-15       Impact factor: 2.692

4.  Functional Gait Can Be Affected by Noise: Effects of Age and Cognitive Function: A Pilot Study.

Authors:  Margot Buyle; Viktoria Azoidou; Marousa Pavlou; Vincent Van Rompaey; Doris-Eva Bamiou
Journal:  Front Neurol       Date:  2021-02-09       Impact factor: 4.003

5.  EHealth and Its Role in Supporting Audiological Rehabilitation: Patient Perspectives on Barriers and Facilitators of Using a Personal Hearing Support System With Mobile Application as Part of the EVOTION Study.

Authors:  Louisa Murdin; Mark Sladen; Hannah Williams; Doris-Eva Bamiou; Athanasios Bibas; Dimitris Kikidis; Apostolis Oiknonomou; Ioannis Kouris; Dimitris Koutsouris; Niels H Pontoppidan
Journal:  Front Public Health       Date:  2022-01-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.